4.5 Review Book Chapter

The Role of MeCP2 in the Brain

Journal

Publisher

ANNUAL REVIEWS
DOI: 10.1146/annurev-cellbio-092910-154121

Keywords

epigenetics; Rett syndrome; methyl-CpG binding domain (MBD); DNA methylation

Funding

  1. MRC [G0800401] Funding Source: UKRI
  2. Medical Research Council [G0800401] Funding Source: Medline
  3. Wellcome Trust Funding Source: Medline

Ask authors/readers for more resources

Methyl-CpG binding protein 2 (MeCP2) was first identified in 1992 as a protein that binds specifically to methylated DNA. Mutations in the MeCP2 gene were later found to be the cause of an autism spectrum disorder, Rett syndrome. Despite almost 20 years of research into the molecular mechanisms of MeCP2 function, many questions are yet to be answered conclusively. This review considers several key questions and attempts to evaluate the current state of evidence. For example, is MeCP2 just a methyl-CpG binding protein? Is it a multifunctional protein or primarily a transcriptional repressor? We also consider whether MeCP2, as a chromosome-binding protein, acts at specific sites within the genome or more globally, and in which cell types it is functionally important. Finally, we consider two alternative views of MeCP2 in the brain: as a regulator of brain development or as a factor that helps maintain neuronal/glial function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available